Antigen | DCMD (n = 30) | Controls (n = 36) | p Value | High grade cIDC* |
---|---|---|---|---|
cIDC, conventional invasive ductal carcinoma; DCMD, ductal carcinoma with myoepithelial differentiation; EGFR, epidermal growth factor receptor; ER, oestrogen receptor; PgR, progesterone receptor. | ||||
EGFR | 21 (70%) | 8 (22%) | 0.002 | 272 (20%) |
HER2/neu | 1 (3%) | 9 (25%) | 0.04 | 52 (30%) |
ER | 3 (10%) | 18 (50%) | 0.001 | 37 (35%) |
PgR | 4 (13%) | 17 (47%) | 0.002 | 7 (44%) |
p53 | 20 (67%) | 5 (14%) | <0.0001 | 55 (47%) |